← FDA DRUG APPROVALS

FDA NDA · NDA019943

LUPRON DEPOT

Sponsor: ABBVIE ENDOCRINE INC

APPLICATION
NDA019943
TYPE
NDA
ORIGINAL APPROVAL
1995-03-30
LATEST ACTION
2025-09-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

LUPRON DEPOTPrescription
LEUPROLIDE ACETATE 3.75MG · INJECTABLE · INJECTION

Approval history

2025-09-10Labeling · Supplement 40 · standardLetterAP
2025-09-10Labeling · Supplement 41 · standardLetterAP
2023-01-27Labeling · Supplement 39 · standardLetterAP
2021-02-12Labeling · Supplement 35 · standardLetterAP
2013-10-30Labeling · Supplement 34 · standardLetterAP
2012-03-28Labeling · Supplement 31 · unknownLetterAP
2012-01-23Labeling · Supplement 33 · unknownLetterAP
2011-06-14Labeling · Supplement 32 · unknownLetterAP
2010-10-29Labeling · Supplement 30 · unknownLabelAP
2009-06-02Labeling · Supplement 29 · standardLetterAP
2007-10-31Labeling · Supplement 26 · standardLetterAP
2005-09-15Labeling · Supplement 24 · standardReviewAP
2005-09-15Manufacturing (CMC) · Supplement 22 · standardLetterAP
2004-01-15Labeling · Supplement 18 · standardLetterAP
2004-01-12Labeling · Supplement 21 · standardLetterAP
2002-09-20Manufacturing (CMC) · Supplement 19 · standardAP
2002-05-23Manufacturing (CMC) · Supplement 17 · standardAP
2002-02-21Manufacturing (CMC) · Supplement 16 · standardAP
2001-11-14Labeling · Supplement 15 · standardAP
2001-03-01Labeling · Supplement 14 · standardAP
2001-01-24Manufacturing (CMC) · Supplement 13 · standardAP
2000-05-12Manufacturing (CMC) · Supplement 12 · standardAP
2000-05-11Manufacturing (CMC) · Supplement 11 · standardAP
1999-08-13Manufacturing (CMC) · Supplement 10 · standardReviewAP
1998-06-30Manufacturing (CMC) · Supplement 9 · standardAP
1997-06-27Manufacturing (CMC) · Supplement 7 · standardAP
1996-09-12Labeling · Supplement 6 · standardAP
1995-12-12Labeling · Supplement 2 · standardAP
1995-10-26Manufacturing (CMC) · Supplement 3 · standardReviewAP
1995-09-22Manufacturing (CMC) · Supplement 1 · standardAP
1995-08-11Manufacturing (CMC) · Supplement 4 · standardAP
1995-03-30Type 5 - New Formulation or New Manufacturer · Original · standardOther Important Information from FDAAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →